Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Celestica (CLS) EBITDA (2016 - 2026)

Celestica has reported EBITDA over the past 18 years, most recently at $272.1 million for Q1 2026.

  • Quarterly EBITDA rose 111.26% to $272.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Mar 2026, up 96.58% year-over-year, with the annual reading at $1.0 billion for FY2025, 73.65% up from the prior year.
  • EBITDA was $272.1 million for Q1 2026 at Celestica, down from $314.4 million in the prior quarter.
  • Over five years, EBITDA peaked at $325.0 million in Q3 2025 and troughed at $40.6 million in Q1 2022.
  • The 5-year median for EBITDA is $125.8 million (2024), against an average of $150.5 million.
  • The largest YoY upside for EBITDA was 135.51% in 2025 against a maximum downside of 2.38% in 2025.
  • A 5-year view of EBITDA shows it stood at $81.6 million in 2022, then surged by 45.34% to $118.6 million in 2023, then soared by 70.83% to $202.6 million in 2024, then surged by 55.18% to $314.4 million in 2025, then decreased by 13.45% to $272.1 million in 2026.
  • Per Business Quant, the three most recent readings for CLS's EBITDA are $272.1 million (Q1 2026), $314.4 million (Q4 2025), and $325.0 million (Q3 2025).